Showing results (541-550 of 561) with videos related to

Sort By:
Pageof 57
Geriatrics & Gerontology International|December 17, 2009
Comprehensive geriatric assessment of elderly highlanders in Qinghai, China I: activities of daily living, quality of life and metabolic syndromeKozo Matsubayashi, Yumi Kimura, Ryota Sakamoto, et al.
European Urology Open Science|November 13, 2023
Overall Survival by Response to First-line Induction Treatment with Atezolizumab plus Platinum-based Chemotherapy or Placebo plus Platinum-based Chemotherapy for Metastatic Urothelial CarcinomaEnrique Grande, Aristotelis Bamias, Matthew D Galsky, et al.
Cancer Cell|January 15, 2016
MiR-215 Is Induced Post-transcriptionally via HIF-Drosha Complex and Mediates Glioma-Initiating Cell Adaptation to Hypoxia by Targeting KDM1BJing Hu, Tao Sun, Hui Wang, et al.
Geriatrics & Gerontology International|December 17, 2009
Comprehensive geriatric assessment of elderly highlanders in Qinghai, China II: the association of polycythemia with lifestyle-related diseases among the three ethnicitiesKiyohito Okumiya, Ryota Sakamoto, Yumi Kimura, et al.
Geriatrics & Gerontology International|December 17, 2009
Comprehensive geriatric assessment of elderly highlanders in Qinghai, China, III: oxidative stress and aging in Tibetan and Han elderly highlandersRyota Sakamoto, Kozo Matsubayashi, Yumi Kimura, et al.
Geriatrics & Gerontology International|December 17, 2009
Comprehensive geriatric assessment of elderly highlanders in Qinghai, China IV: comparison of food diversity and its relation to health of Han and Tibetan elderlyYumi Kimura, Kiyohito Okumiya, Ryota Sakamoto, et al.
International Journal of Clinical Oncology|January 21, 2026
Pan-Asian subgroup analysis of EV-302/KEYNOTE-A39: a phase 3 study to evaluate enfortumab vedotin and pembrolizumab in patients with untreated advanced urothelial carcinomaEiji Kikuchi, Michiel S Van der Heijden, Begoña P Valderrama, et al.
The New England Journal of Medicine|March 6, 2024
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial CancerThomas Powles, Begoña P Valderrama, Shilpa Gupta, et al.
The Lancet. Oncology|December 15, 2023
Atezolizumab plus chemotherapy versus placebo plus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis results from a randomised, controlled, phase 3 studyEnrique Grande, José Á Arranz, Maria De Santis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2022
FORT-1: Phase II/III Study of Rogaratinib Versus Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Selected Based on FGFR1/3 mRNA ExpressionCora N Sternberg, Daniel P Petrylak, Joaquim Bellmunt, et al.
Pageof 57